Hansoh Pharmaceutical Group Company Limited announced unaudited consolidated earnings results for the six months ended June 30, 2021. For the period, the company reported revenue of RMB 4,401,501,000 against RMB 3,979,518,000 a year ago. Profit for the period was RMB 1,290,590,000 against RMB 1,221,834,000 a year ago. Basic earnings per share attributable to ordinary equity holders of the parent for the period was RMB 0.22 against RMB 0.21 a year ago. Diluted earnings per share attributable to ordinary equity holders of the parent for the period was RMB 0.20 against RMB 0.21 a year ago.